Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 8 485 / https://doi.org/10.3332/ecancer.2014.485

Clinical Study

Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent

Cimetidine, the first H2 receptor antagonist in widespread clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical and clinical studies for a number of different cancer types. These data are summarised and discussed in relation to a number of distinct mechanisms of action. Based on the evidence presented, it is proposed that cimetidine would synergise with a range of other drugs, including existing chemotherapeutics, and that further exploration of the potential of cimetidine as an anti-cancer therapeutic is warranted. Furthermore, there is compelling evidence that cimetidine administration during the peri-operative period may provide a survival benefit in some cancers. A number of possible combinations with other drugs are discussed in the supplementary material accompanying this paper.

Keywords: Drug repurposing, cimetidine, immunostimulant, ReDO project

Loading Article Metrics ... Please wait

Related articles

Special Issue: mHealth and telemedicine apps: in search of a common regulation

Abstract | Full Article | PDF Published: 11 Jul 2018 / https://doi.org/10.3332/ecancer.2018.853

Special Issue: Development of an eHealth tool for cancer patients: monitoring psychoemotional aspects with the family resilience (FaRe) questionnaire

Abstract | Full Article | PDF Published: 11 Jul 2018 / https://doi.org/10.3332/ecancer.2018.852

Special Issue: Personal health information recommender: implementing a tool for the empowerment of cancer patients

Abstract | Full Article | PDF Published: 11 Jul 2018 / https://doi.org/10.3332/ecancer.2018.851

Special Issue: The role of serious games in the iManageCancer project

Abstract | Full Article | PDF Published: 11 Jul 2018 / https://doi.org/10.3332/ecancer.2018.850

Special Issue: MyHealthAvatar lifestyle management support for cancer patients

Abstract | Full Article | PDF Published: 11 Jul 2018 / https://doi.org/10.3332/ecancer.2018.849



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence